BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 18227828)

  • 1. Advances in the systemic therapy of malignant pleural mesothelioma.
    Fennell DA; Gaudino G; O'Byrne KJ; Mutti L; van Meerbeeck J
    Nat Clin Pract Oncol; 2008 Mar; 5(3):136-47. PubMed ID: 18227828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant pleural mesothelioma: current treatments and emerging drugs.
    Belli C; Fennell D; Giovannini M; Gaudino G; Mutti L
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):423-37. PubMed ID: 19552609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapies in malignant pleural mesothelioma: a review of clinical studies.
    Greillier L; Marco S; Barlesi F
    Anticancer Drugs; 2011 Mar; 22(3):199-205. PubMed ID: 21263312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of malignant pleural mesothelioma.
    West SD; Lee YC
    Clin Chest Med; 2006 Jun; 27(2):335-54. PubMed ID: 16716822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and management of malignant pleural mesothelioma.
    Zucali PA; Giaccone G
    Eur J Cancer; 2006 Nov; 42(16):2706-14. PubMed ID: 16989994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the biology of malignant pleural mesothelioma.
    Zucali PA; Ceresoli GL; De Vincenzo F; Simonelli M; Lorenzi E; Gianoncelli L; Santoro A
    Cancer Treat Rev; 2011 Nov; 37(7):543-58. PubMed ID: 21288646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for malignant pleural mesothelioma.
    Janne PA
    Clin Lung Cancer; 2003 Sep; 5(2):98-106. PubMed ID: 14596692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review on clinical trials of targeted treatments in malignant mesothelioma.
    Jakobsen JN; Sørensen JB
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):1-15. PubMed ID: 21553148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma.
    Sterman DH; Albelda SM
    Respirology; 2005 Jun; 10(3):266-83. PubMed ID: 15955137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
    Reck M; Heigener DF; Gatzemeier U
    Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for malignant pleural mesothelioma: past results and recent developments.
    Tomek S; Manegold C
    Lung Cancer; 2004 Aug; 45 Suppl 1():S103-19. PubMed ID: 15261443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mesothelioma 2008.
    Zervos MD; Bizekis C; Pass HI
    Curr Opin Pulm Med; 2008 Jul; 14(4):303-9. PubMed ID: 18520263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future developments in the management of malignant pleural mesothelioma.
    Zucali PA; De Vincenzo F; Simonelli M; Santoro A
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):453-67. PubMed ID: 19374599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development.
    Fennell DA; Rudd RM
    Lancet Oncol; 2004 Jun; 5(6):354-62. PubMed ID: 15172356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational therapies for malignant pleural mesothelioma.
    Belli C; Anand S; Tassi G; Fennell D; Mutti L
    Expert Rev Respir Med; 2010 Apr; 4(2):249-60. PubMed ID: 20406091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in malignant pleural mesothelioma.
    Kaufman AJ; Pass HI
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemetrexed for malignant pleural mesothelioma: Is it a standard second-line therapy?
    Tamura K; Fujiwara Y
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):248-50. PubMed ID: 21114772
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic options in malignant pleural mesothelioma].
    Serke M; Loddenkemper R
    Pneumologie; 2005 May; 59(5):337-48. PubMed ID: 15902599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising survival in malignant mesothelioma.
    Baas P
    Lung Cancer; 2007 Aug; 57 Suppl 2():S24-9. PubMed ID: 17686442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.
    Jassem J; Ramlau R; Santoro A; Schuette W; Chemaissani A; Hong S; Blatter J; Adachi S; Hanauske A; Manegold C
    J Clin Oncol; 2008 Apr; 26(10):1698-704. PubMed ID: 18375898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.